Is there any legitimate reason a tophat bam file would have reads for a gene whose RPKM was not reported in the output from tophat or cufflinks?
Unconfigured Ad
Collapse
X
-
You are finding reads in tophat bam file that are not reported in output from tophat (which is .bam format)? I don't really understand your question-can you give an example.Originally posted by mgogol View PostIs there any legitimate reason a tophat bam file would have reads for a gene whose RPKM was not reported in the output from tophat or cufflinks?
I thought tophat uses FPKM units and not RKPM.
-
If I look at the list of genes whose FPKMs are reported by cufflinks, a certain group of genes is not found in that list at all.
If I load a bam file generated from the tophat sam file into IGV, and browse around looking at those genes, they have reads. So they have reads, but FPKMs are not reported.
I'm just wondering if this an error or if there is some legitimate explanation?
Comment
-
if the reads are too few, they may be filtered by the F/--min-isoform-fraction parameter where TopHat filters out junctions supported by too few alignments.
May be you can set it to 0.
Also, I don't intuitively understand -a/--min-anchor-length <int> parameter, but it may also be limiting your reads that are counted for the FPKM.
Comment
-
sure, if you find out whats going on, let us know. If the reads you saw on IGV don't span junctions, then its probably a parameter in bowtie that is throwing it- off-low quality or reads mapping to multiple places in the genome or something else. Its a good thing you caught it though
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
53 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
40 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
46 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
46 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment